Fulgent Genetics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Fulgent Genetics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 53% to $289,213,000. Profit margin reached -58%. Total operating expenses were $171,906,000.

Profit Margin

Fulgent Genetics, Inc. (NASDAQ:FLGT): Profit margin
2014 1.27M -4.28M -335.13%
2015 9.57M -8.31M -86.82%
2016 18.27M -5.38M -29.48%
2017 18.73M -2.66M -14.21%
2018 21.35M -4.48M -21.02%
2019 32.52M 366K 1.13%
2020 421.71M 214.31M 50.82%
2021 992.58M 507.36M 51.12%
2022 618.96M 143.40M 23.17%
2023 289.21M -167.82M -58.03%

FLGT Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
289.21M618.96M992.58M421.71M32.52M21.35M18.73M18.27M9.57M1.27M
Cost of revenue
184.75M252.06M215.53M89.80M14.10M10.69M8.55M6.72M5.06M936K
Gross profit
104.45M366.90M777.05M331.90M18.42M10.66M10.17M11.55M4.50M342K
Operating exp.
Research and development
41.44M28.91M24.21M11.58M6.53M5.53M4.22M3.55M4.43M521K
Selling and marketing
41.46M38.91M24.43M14.95M5.89M4.65M4.22M2.46M2.67M581K
Total operating expenses
171.90M185.39M101.09M41.74M18.84M15.72M13.57M10.63M9.51M1.33M
Operating income
-72.69M178.52M675.95M290.15M-428K-5.05M-3.4M919K-5.01M-990K
Other income (expenses), net
-101.39M5.49M1.34M1.52M837K434K481K-5.38M27K0
Income before tax
-174.08M184.02M677.3M291.68M409K-4.62M-2.91M-4.46M-4.98M-990K
Income tax expense
1.15M42.10M174.79M72.53M43K-1.06M-768K920K3.32M3.29M
Net income
-167.82M143.40M507.36M214.31M366K-4.48M-2.66M-5.38M-8.31M-4.28M
Earnings per share
Basic EPS
-5.634.7617.139.640.01-0.25-0.15-0.3-0.65-0.34
Diluted EPS
-5.634.6316.269.090.01-0.25-0.15-0.3-0.65-0.34
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData source